Targeting one-carbon metabolism by methyl donors for prevention of non-alcoholic fatty liver in rats

被引:0
|
作者
Al Doghaither, Huda Abdulaziz [1 ]
机构
[1] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia
来源
关键词
One-Carbon Metabolism; L-Methionine; Choline; Folic Acid; Methyl Donors; BIOMARKERS; DISEASE;
D O I
10.4328/ACAM.21802
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: The purpose of the current work was to demonstrate and compare the impacts of folate, methionine, and choline as methyl donors in the prevention of NAFLD induced by a high-fructose diet (HFrD). Material and Methods: Sixty adult male albino rats were divided into five groups: G1 had a control-fed basal diet; in G2, the rats were fed an HFrD containing 45% fructose (HFrD); in G3, G4, and G5, the rats were fed an HFrD supplemented with folic acid, L-methionine, and choline chloride, respectively. The present study's findings showed a close connection between methyl donors and lipid metabolism. Results: The findings indicated that the folic acid supplemented diet (HFrD+ folate) exhibited the most substantial improvement in hepatic total lipids (TP), triacylglycerol (TG), phospholipid (PL), serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), free fatty acid (FFA), albumin (ALB), total bile acid (TBA), fasting blood glucose (FBG), proinflammatory cytokines levels, and enzyme activities of alanine transaminase (ALT), aspartate transaminase (AST), fatty acid synthase (FAS), and acetyl coenzyme A carboxylase (ACC). In the same context, L-methionine had the most significant improvement in oxidative stress biomarker (glutathione [GSH], superoxide dismutase [SOD], 4-hydroxynonenal [4-HNE]) levels, followed by folic acid and choline. Discussion: Methyl donors such as folic acid, methionine, and choline are essential for maintaining OCM and can prevent animals with NAFLD from developing liver lipid accumulation.
引用
收藏
页码:830 / 834
页数:5
相关论文
共 50 条
  • [21] Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy
    Tian, Yingxin
    Ni, Yiming
    Zhang, Ting
    Cao, Yemin
    Zhou, Mingmei
    Zhao, Cheng
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [22] Targeting the Gut Microbiota for the Treatment of Non-Alcoholic Fatty Liver Disease
    Mouzaki, Marialena
    Bandsma, Robert
    CURRENT DRUG TARGETS, 2015, 16 (12) : 1324 - 1331
  • [23] Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit?
    Merli, Manuela
    Dasarathy, Srinivasan
    JOURNAL OF HEPATOLOGY, 2015, 63 (02) : 309 - 311
  • [24] Targeting histone methylation and demethylation for non-alcoholic fatty liver disease
    Du, Yuanbing
    He, Zhangxu
    Jin, Sasa
    Jin, Gang
    Wang, Kaiyue
    Yang, Feifei
    Zhang, Jingyu
    BIOORGANIC CHEMISTRY, 2024, 151
  • [25] Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
    Kim, Tae Hyun
    Hong, Dong-Gyun
    Yang, Yoon Mee
    BIOMEDICINES, 2021, 9 (12)
  • [26] Metabolism of human liver on a genome scale in non-alcoholic fatty liver disease
    Sen, Parho
    Govaere, Olivier
    McGlinchey, Aidan
    Ratziu, Vlad
    Bugianesi, Elisabetta
    Schattenberg, Jorn M.
    Allison, Michael
    Cockell, Simon
    Daly, Ann K.
    Hyotylainen, Tuulia
    Anstee, Quentin
    Oresic, Matej
    JOURNAL OF HEPATOLOGY, 2020, 73 : S671 - S672
  • [27] Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
    Tacke, Frank
    Weiskirchen, Ralf
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [28] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [29] Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism
    Wang, Songsong
    Sheng, Feiya
    Zou, Liang
    Xiao, Jianbo
    Li, Peng
    JOURNAL OF ADVANCED RESEARCH, 2021, 34 : 109 - 122
  • [30] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693